BioGaia AB (publ) (LON: 0GTN)
London
· Delayed Price · Currency is GBP · Price in SEK
116.50
+0.60 (0.52%)
At close: Jan 21, 2025
BioGaia AB Revenue
BioGaia AB had revenue of 303.97M SEK in the quarter ending September 30, 2024, a decrease of -4.32%. This brings the company's revenue in the last twelve months to 1.36B, up 6.49% year-over-year. In the year 2023, BioGaia AB had annual revenue of 1.30B with 17.44% growth.
Revenue (ttm)
1.36B SEK
Revenue Growth
+6.49%
P/S Ratio
n/a
Revenue / Employee
6.46M SEK
Employees
210
Market Cap
870.17M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
Dec 31, 2019 | 768.35M | 26.48M | 3.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 221.41B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |